|
|
| (3 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| |
| {{COVID-19 thyroid disorders}}
| |
|
| |
|
| {{CMG}} {{AE}}
| |
|
| |
| ==Overview==
| |
|
| |
| Many covid-19 patients eventually develop thyroid disorders. 90% of them develop hyperthyroidism, while the rest of them develop hypothyroidism.<ref name="pmid32438340">{{cite journal| author=Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L| title=ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism. | journal=Eur J Endocrinol | year= 2020 | volume= 183 | issue= 1 | pages= G33-G39 | pmid=32438340 | doi=10.1530/EJE-20-0445 | pmc=7938012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32438340 }} </ref>
| |
|
| |
| ==Historical Perspective==
| |
|
| |
| ==Classification==
| |
|
| |
| ==Pathophysiology==
| |
|
| |
| ==Causes==
| |
|
| |
| ==Differentiating ((Page name)) from other Diseases==
| |
|
| |
| ==Epidemiology and Demographics==
| |
|
| |
| ==Risk Factors==
| |
|
| |
| ==Screening==
| |
|
| |
| ==Natural History, Complications, and Prognosis==
| |
|
| |
| ==Diagnosis==
| |
| ===Diagnostic Study of Choice===
| |
|
| |
| ===History and Symptoms===
| |
|
| |
| ===Physical Examination===
| |
|
| |
| ===Laboratory Findings===
| |
|
| |
| ===Electrocardiogram===
| |
|
| |
| ===X-ray===
| |
|
| |
| ===Echocardiography or Ultrasound===
| |
|
| |
| ===CT scan===
| |
|
| |
| ===MRI===
| |
|
| |
| ===Other Imaging Findings===
| |
|
| |
| ===Other Diagnostic Studies===
| |
|
| |
|
| |
| ==Treatment==
| |
| ===Medical Therapy===
| |
|
| |
| ===Surgery===
| |
|
| |
| ===Primary Prevention===
| |
|
| |
| ===Secondary Prevention===
| |
|
| |
| ==References==
| |